| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||||
|---|---|---|---|---|---|---|---|---|
| 2016-12-29 |
TetraLogic Pharmaceuticals Corp. - Oncology Programs
Life Science Malvern, Pennsylvania TetraLogic Pharmaceuticals Corp. - Oncology Programs includes clinical stage oncology programs MAC Mimetic and HDAC Inhibitor Assets. |
Divestiture
|
Medivir
|
TetraLogic Pharmaceuticals
|
||||
| Deal Article Deal Link | ||||||||
| 2016-12-28 |
Pilus Energy LLC
Life Science Cincinnati, Ohio www.pilusenergy.com Pilus Energy LLC is a developer of microbial solutions that clean polluting molecules from wastewater. |
Divestiture |
Open Therapeutics LLC
|
Tauriga Sciences, Inc.
|
||||
| Deal Article Deal Link | ||||||||
| 2016-12-23 |
Taro Pharmaceutical Industries Ltd. - U.S. Rights to KEVEYIS
Life Science Trevose, Pennsylvania www.keveyis.com Taro Pharmaceutical Industries Ltd. - U.S. Rights to KEVEYIS (dichlorphenamide) is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. |
Divestiture
|
Strongbridge Biopharma
|
Taro Pharmaceutical Industries
|
||||
| Deal Link | ||||||||
| 2016-12-19 |
iuvo BioScience LLC - Ethylene Oxide Contract Sterilization Operation
Life Science Rush, New York iuvo BioScience LLC - Ethylene Oxide Contract Sterilization Operation is a provider of life science products. |
Divestiture |
iuvo
|
Cosmed
|
||||
| Deal Article Deal Link | ||||||||
| 2016-12-14 |
DuPont - Food Safety Diagnostics Business
Life Science Wilmington, Delaware DuPont - Food Safety Diagnostics Business is a provider of science based microbial detection and monitoring products that identify and characterize pathogens and other unwelcome organisms in food ingredients, finished products and production environments. |
Divestiture |
Hygiena LLC
|
DuPont
|
||||
| Deal Link | ||||||||
| 2016-12-07 |
Fertin
Life Science Vejle, Denmark www.fertin.com Fertin develops and manufactures pharmaceutical and nutraceutical products for leading global companies to support healthier living. Fertin’s product portfolio has a broad variety of current and possible application areas including Nicotine Replacement Therapy, oral care, gastrointestinal, pain and allergy management, cough and cold, and much more. Fertin was founded in 1915 and is based in Vejle, Denmark. |
Divestiture |
EQT
Bagger-Sorensen Group
|
Bagger-Sorensen Group
|
||||
| Deal Article Deal Link | ||||||||
| 2016-12-02 |
Identigene LLC
Life Science Fairfield, Ohio www.dnatesting.com Identigene LLC is a provider of DNA paternity testing, providing both personal and legal paternity tests, as well as another relationship testing, such as grand-parentage and siblingship. Identigene was founded in 1993 and is based in Fairfield, Ohio. |
Divestiture |
DNA Diagnostics Center (DDC)
|
Sorenson Genomics LLC
|
||||
| Deal Article Deal Link | ||||||||
| 2016-11-25 |
PediaCare
Life Science Staten Island, New York www.pediacare.com PediaCare is a provider of products for children, primarily within cough cold and analgesics segments. |
Divestiture
|
Strides Pharma Science
|
Moberg Pharma
|
||||
| Deal Article Deal Link | ||||||||
| 2016-11-15 |
AMEGABIOTECH - Interferon Alpha Manufacturing Technology
Life Science Argentina AMEGABIOTECH - Interferon Alpha Manufacturing Technology is a key component of Neovacs’ lead therapeutic candidate, IFNα Kinoid, which is composed of inactivated IFNα coupled with a carrier protein, keyhole limpet hemocyanin. |
Divestiture |
Neovacs
|
Amega Biotech
|
||||
| Deal Link | ||||||||
| 2016-11-11 |
SERI Surgical Scaffold
Life Science Parsippany, New Jersey www.seri.com SERI Surgical Scaffold is a provider of silk based solutions to treat patients with soft-tissue defects. |
Divestiture |
Sofregen Medical
|
Allergan
|
||||
| Deal Article Deal Link | ||||||||
| 2016-11-03 |
AMP Therapeutics GmbH - Anti-Microbial Peptide
Life Science Leipzig, Germany AMP Therapeutics GmbH - Anti-Microbial Peptide comprises the first line of defense against infection through the innate immune system. The AMPT portfolio of unique antimicrobial peptides overcomes many of the issues associated with AMPs as anti-bacterial therapeutics, most notably potency, spectrum, stability and toxicity. The unique mechanism of action of these compounds and the low rate of resistance development positions these molecules as the next generation of novel anti-bacterials. |
Divestiture |
EnBiotix, Inc.
|
AMP Therapeutics GmbH
|
||||
| Deal Article Deal Link | ||||||||
| 2016-11-01 |
Biophausia AB
Life Science Stockholm, Sweden www.biophausia.se Biophausia AB is a pharmaceutical company. Biophausia provides cost-effective pharmaceuticals and focuses on three fields: generic products, niche products and original drugs.
|
Divestiture
|
Karo Healthcare
|
Medivir
|
||||
| Deal Article Deal Link | ||||||||
| 2016-10-28 |
IDT Australia Ltd. - CMAX Clinical Trial Business
Life Science Boronia, Australia IDT Australia Ltd. - CMAX Clinical Trial Business offers a full suite of clinical trial services including Phase I clinical trials management and delivery, recruitment in specific disease states for Phase II and Phase III trials. |
Divestiture
|
I'rom Group Co. Ltd.
|
IDT Australia
|
||||
| Deal Link | ||||||||
| 2016-10-27 |
Motus Therapeutics, Inc.
Life Science Boston, www.motustx.com Motus Therapeutics, Inc. is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases. |
Divestiture |
Rhythm Pharmaceuticals, Inc.
|
Allergan
|
||||
| Deal Link | ||||||||
| 2016-10-12 |
Avrio Biopharmaceuticals LLC
Life Science Irvine, California Avrio Biopharmaceuticals LLC is a cGMP contract development and manufacturing organization supporting the pharmaceutical and biopharmaceutical industries from Phase I through post-market life cycle management. With a state-of-the-art facility, experienced staff, and robust quality infrastructure, Avrio delivers client-centric solutions in a timely manner. |
Divestiture |
Nitto Denko Avecia, Inc.
|
Irvine Pharmaceutical Services, Inc.
|
||||
| Deal Article Deal Link | ||||||||
| 2016-10-05 |
Boehringer Ingelheim Vetmedica, Inc. - U.S. Feline, Canine and Rabies Vaccines
Life Science St. Joseph, Montana Boehringer Ingelheim Vetmedica, Inc. - U.S. Feline, Canine and Rabies Vaccines is a developer of vaccines for animals. The business also inculded fully integrated manufacturing and R&D site. |
Divestiture
|
Elanco
|
Boehringer Ingelheim Vetmedica, Inc.
|
||||
| Deal Article Deal Link | ||||||||
| Avg |
$263
0.0x EBITDA 3.8x REVENUE |
|||||||
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.